Inverted pyramid of prenatal care – is it enough? Should it be – extended inverted pyramid of prenatal care?

References

[1] Nicolaides K. A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn. 2011;31:3–6.10.1002/pd.2685Search in Google Scholar

[2] Sonek JD, Cuckle HS. What will be the role of first-trimester ultrasound if cell-free DNA screening for aneuploidy becomes routine? Ultrasound Obstet Gynecol. 2014;44:621–30.10.1002/uog.14692Search in Google Scholar

[3] Greco E, Lange A, Ushakov F, Rodriguez Calvo J, Nicolaides KH. Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks. Prenat Diagn. 2011;31:84–9.10.1002/pd.2640Search in Google Scholar

[4] Poon NC, Nicolaides K. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:11.10.1155/2014/297397Search in Google Scholar

[5] Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn. 2011;31:66–74.10.1002/pd.2660Search in Google Scholar

[6] Mihailović M, Cvetković M, Ljubić A, Kosanović M, Nedeljković S, Jovanović I, et al. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biol Trace Elem Res. 2000;73:47–54.10.1385/BTER:73:1:47Search in Google Scholar

[7] Cetković A, Miljic D, Ljubić A, Patterson M, Ghatei M, Stamenković J, et al. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome. Endocr Res. 2012;37:78–88.10.3109/07435800.2011.639319Search in Google Scholar PubMed

[8] Giguère Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem. 2010;56:361–75.10.1684/abc.2011.0572Search in Google Scholar PubMed

[9] Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents in preventing pre-eclampsia. Cohrane. 2007;2.10.1002/14651858.CD004659.pub2Search in Google Scholar PubMed

[10] Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides K. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther. 2011;29:148–54.10.1159/000321694Search in Google Scholar PubMed

[11] Urato AC, Norwitz ER. A guide towards pre-pregnancy management of defective implantation and placentation. Best Pract Res Clin Obstet Gynaecol. 2011;25:367–87.10.1016/j.bpobgyn.2011.01.003Search in Google Scholar

[12] Leach M, Aitken R, Sacks G. Sperm DNA fragmentation abnormalities in men from couples with a history of recurrent miscarriage. Aust N Z J Obstet Gynaecol. 2015;55:379–3.10.1111/ajo.12373Search in Google Scholar

[13] Gil M, Shalom V, Carreras S. Sperm selection using magnetic activated cell sorting (MACS) in assisted reproduction: a systematic review and meta-analysis. J Assist Reprod Genet. 2013;30:479–85.10.1007/s10815-013-9962-8Search in Google Scholar

[14] Evgeni E, Byron A. Human sperm DNA fragmentation and its correlation with conventional semen parameters. J Reprod Infertil. 2014;15:2–14.Search in Google Scholar

[15] Wong CC, Loewke KE, Bossert NL, Behr B, De Jonge CJ, Baer TM, et al. Non-invasive imaging of human embryos before embryonic genome activation pre- dicts development to the blastocyst stage. Nat Biotechnol. 2010;28:1115–21.10.1038/nbt.1686Search in Google Scholar

[16] Seli E, Robert C, Sirard MA. OMICS in assisted reproduction: possibilities and pitfalls. Mol Hum Reprod. 2010;16:513–30.10.1093/molehr/gaq041Search in Google Scholar

[17] Menezo Y, Elder K, Benkhalifa S, Dale B. DNA methylation and gene expression in IVF. Reprod Biomed Online. 2010;20:709–10.10.1016/j.rbmo.2010.02.016Search in Google Scholar

[18] Nagy ZP, Jones-Colon S, Roos P, Botros L, Greco E, Dasig J, et al. Metabolomic assessment of oocyte viability. Reprod Biomed Online. 2009;18:219–25.10.1016/S1472-6483(10)60259-3Search in Google Scholar

[19] Tejera A, Herero J, de Los Santos MJ, Garrido N, Ramsing N, Meseguer M. Oxygen consumption is a quality marker for human oocyte competence conditioned by ovarian stimulation regimens. Fertil Steril. 2011;96:618–23.10.1016/j.fertnstert.2011.06.059Search in Google Scholar PubMed

[20] Cheng Y, Feng Y, Jansson L, Sato Y, Deguchi M, Kawamura K, et al. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. FASEB J. 2015;29:2423–30.10.1096/fj.14-267856Search in Google Scholar PubMed PubMed Central

[21] Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145–50.10.1038/nature02316Search in Google Scholar PubMed

[22] Hayashi K, Ogushi S, Kurimoto K, Shimamoto S, Ohta H, Saitou M. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science. 2012;338:971–5.10.1126/science.1226889Search in Google Scholar

[23] Edessy M. Successful autologous stem cell therapy of premature ovarian failure. Egyptian J Histol. 2013;36: 114–126.10.15406/mojwh.2015.01.00013Search in Google Scholar

[24] Callejo J, Salvador C, González-Nuñez S, Almeida L, Rodriguez L, Marqués L, et al. Live birth in a woman without ovaries after autograft of frozen-thawed ovarian tissue combined with growth factors. J Ovarian Res. 2013;6:33–6.10.1186/1757-2215-6-33Search in Google Scholar

[25] Smeets HJM. Preventing the transmission of mitochondrial DNA disorders: Selecting the good guys or kicking out the bad guys. Reprod BioMed Online. 2013;27:599–610.10.1016/j.rbmo.2013.08.007Search in Google Scholar

[26] Amato P, Tachibana M, Sparman M, Mitalipov. Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases. Fertil Steril. 2014;101:31–5.10.1016/j.fertnstert.2013.11.030Search in Google Scholar

[27] Mitalipov S, Wolf DP. Clinical and ethical implications of mitochondrial gene transfer. Trends Endocrinol Metab. 2014;25:5–7.10.1016/j.tem.2013.09.001Search in Google Scholar

[28] Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110:17474–9.10.1073/pnas.1312830110Search in Google Scholar

[29] Ljubić et al. Autologous ovarian in vitro activation with ultrasound-guided orthotopic re-transplantation. Am j Clin Exp Obstst Gynecol. 2017. (In press)Search in Google Scholar

[30] Stephenson MD, Fluker MR. Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial. Fertil Steril. 2000;74:1108–13.10.1016/S0015-0282(00)01622-8Search in Google Scholar

[31] Stern C, Chamley L, Norris H, Hale L, Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril. 2003;80:376–83.10.1016/S0015-0282(03)00610-1Search in Google Scholar

[32] Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Data Base Syst Rev. 2007:CD005996.10.1002/14651858.CD005996.pub2Search in Google Scholar PubMed

[33] Gelbaya TA, Kyrgiou M, Li TC, Stern C, Nardo LG. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2007;13:357–64.10.1093/humupd/dmm005Search in Google Scholar PubMed

[34] Sumarac-Dumanovic M, Apostolovic M, Janjetovic K, Jeremic D, Popadic D, Ljubic A, et al. Downregulation of autophagy gene expression in endometria from women with polycystic ovary syndrome. Mol Cell Endocrinol. 2017;440:116–24.10.1016/j.mce.2016.11.009Search in Google Scholar PubMed

[35] Yoshioka S, Fujiwara H, Nakayma T, Kosaka K, Mori T, Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer. Hum Reprod. 2006;21:3290–4.10.1093/humrep/del312Search in Google Scholar PubMed

[36] Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris AN, Coukos G, et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol. 2001;2:1018–24.10.1038/ni719Search in Google Scholar PubMed

[37] Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E, et al. Granulocyte colony-stimulating factor and endometrium. Human Reprod. 2013;28:172–7.10.1093/humrep/des370Search in Google Scholar PubMed

[38] Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcomeduring in vitro fertilization. Int J Clin Exp Med. 2015;8:1286–90.Search in Google Scholar

[39] Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2010;94:1700–6.10.1016/j.fertnstert.2009.10.015Search in Google Scholar PubMed

[40] Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil Steril. 2011;96:638–40.10.1016/j.fertnstert.2011.06.049Search in Google Scholar PubMed

[41] Bisignano A, Wells D, Harton G, Munne S. PGD and aneuploidy screening for 24 chromosomes: advantages and disadvantages of competing platforms. Reprod Biomed Online. 2011;23:677–85.10.1016/j.rbmo.2011.05.017Search in Google Scholar PubMed